Aemetis (NASDAQ:AMTX) Upgraded to Sell at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research note published on Wednesday morning.

Separately, HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research note on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Price Performance

NASDAQ:AMTX opened at $2.11 on Wednesday. The company has a market capitalization of $104.95 million, a P/E ratio of -0.93 and a beta of 1.44. The business has a fifty day simple moving average of $2.82 and a two-hundred day simple moving average of $2.86. Aemetis has a 1 year low of $2.04 and a 1 year high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter in the previous year, the company posted ($0.59) earnings per share. As a group, analysts anticipate that Aemetis will post -2.07 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AMTX. Bank of New York Mellon Corp boosted its holdings in shares of Aemetis by 29.6% in the 4th quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock worth $247,000 after purchasing an additional 20,961 shares in the last quarter. SG Americas Securities LLC bought a new stake in Aemetis in the 4th quarter worth approximately $87,000. Clear Harbor Asset Management LLC purchased a new stake in Aemetis in the fourth quarter worth approximately $44,000. Barclays PLC grew its position in Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after acquiring an additional 34,816 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Aemetis by 7.7% during the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after acquiring an additional 66,031 shares in the last quarter. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.